# Vitamin K as Additive Treatment in Osteoporosis

> **NCT01232647** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 105 (actual)

## Conditions studied

- Post-menopausal Osteoporosis

## Interventions

- **DRUG:** Phylloquinone
- **DRUG:** Menatetrenone (MK4)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01232647
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232647, "Vitamin K as Additive Treatment in Osteoporosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01232647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*